204 related articles for article (PubMed ID: 18338251)
81. The role of survivin in the resistance of endometriotic stromal cells to drug-induced apoptosis.
Watanabe A; Taniguchi F; Izawa M; Suou K; Uegaki T; Takai E; Terakawa N; Harada T
Hum Reprod; 2009 Dec; 24(12):3172-9. PubMed ID: 19729377
[TBL] [Abstract][Full Text] [Related]
82. Transfection of Smac/DIABLO sensitizes drug-resistant tumor cells to TRAIL or paclitaxel-induced apoptosis in vitro.
Mao HL; Liu PS; Zheng JF; Zhang PH; Zhou LG; Xin G; Liu C
Pharmacol Res; 2007 Dec; 56(6):483-92. PubMed ID: 18029193
[TBL] [Abstract][Full Text] [Related]
83. The Neuroprotective Effect of miR-181a After Oxygen-Glucose Deprivation/Reperfusion and the Associated Mechanism.
Liu X; Hong L; Peng W; Jiang J; Peng Z; Yang J
J Mol Neurosci; 2019 Jun; 68(2):261-274. PubMed ID: 30949956
[TBL] [Abstract][Full Text] [Related]
84. X-linked inhibitor regulating TRAIL-induced apoptosis in chemoresistant human primary glioblastoma cells.
Roa WH; Chen H; Fulton D; Gulavita S; Shaw A; Th'ng J; Farr-Jones M; Moore R; Petruk K
Clin Invest Med; 2003 Oct; 26(5):231-42. PubMed ID: 14596484
[TBL] [Abstract][Full Text] [Related]
85. Bcl-2 and Bcl-xL inhibit CD95-mediated apoptosis by preventing mitochondrial release of Smac/DIABLO and subsequent inactivation of X-linked inhibitor-of-apoptosis protein.
Sun XM; Bratton SB; Butterworth M; MacFarlane M; Cohen GM
J Biol Chem; 2002 Mar; 277(13):11345-51. PubMed ID: 11801595
[TBL] [Abstract][Full Text] [Related]
86. Relationship between expression of Smac and Survivin and apoptosis of primary hepatocellular carcinoma.
Bao ST; Gui SQ; Lin MS
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):580-3. PubMed ID: 17085346
[TBL] [Abstract][Full Text] [Related]
87. Ischemic preconditioning: neuronal survival in the face of caspase-3 activation.
Tanaka H; Yokota H; Jover T; Cappuccio I; Calderone A; Simionescu M; Bennett MV; Zukin RS
J Neurosci; 2004 Mar; 24(11):2750-9. PubMed ID: 15028768
[TBL] [Abstract][Full Text] [Related]
88. Direct interaction of Smac with NADE promotes TRAIL-induced apoptosis.
Yoon K; Jang HD; Lee SY
Biochem Biophys Res Commun; 2004 Jun; 319(2):649-54. PubMed ID: 15178455
[TBL] [Abstract][Full Text] [Related]
89. Role of Smac/DIABLO in cancer progression.
Martinez-Ruiz G; Maldonado V; Ceballos-Cancino G; Grajeda JP; Melendez-Zajgla J
J Exp Clin Cancer Res; 2008 Sep; 27(1):48. PubMed ID: 18822137
[TBL] [Abstract][Full Text] [Related]
90. The kinetics of translocation of Smac/DIABLO from the mitochondria to the cytosol in HeLa cells.
Springs SL; Diavolitsis VM; Goodhouse J; McLendon GL
J Biol Chem; 2002 Nov; 277(48):45715-8. PubMed ID: 12364342
[TBL] [Abstract][Full Text] [Related]
91. Biophysical characterization of the interaction between the full-length XIAP and Smac/DIABLO.
Polykretis P; Luchinat E
Biochem Biophys Res Commun; 2021 Sep; 568():180-185. PubMed ID: 34247143
[TBL] [Abstract][Full Text] [Related]
92. A single amino acid change (Asp 53 --> Ala53) converts Survivin from anti-apoptotic to pro-apoptotic.
Song Z; Liu S; He H; Hoti N; Wang Y; Feng S; Wu M
Mol Biol Cell; 2004 Mar; 15(3):1287-96. PubMed ID: 14699067
[TBL] [Abstract][Full Text] [Related]
93. Disturbed XIAP and XAF1 expression balance is an independent prognostic factor in gastric adenocarcinomas.
Shibata T; Noguchi T; Takeno S; Gabbert HE; Ramp U; Kawahara K
Ann Surg Oncol; 2008 Dec; 15(12):3579-87. PubMed ID: 18807090
[TBL] [Abstract][Full Text] [Related]
94. SMAC-expression in denervated human skeletal muscle as a potential inhibitor of coexpressed inhibitor-of-apoptosis proteins.
Tews DS; Behrhof W; Schindler S
Appl Immunohistochem Mol Morphol; 2008 Jan; 16(1):66-70. PubMed ID: 18091317
[TBL] [Abstract][Full Text] [Related]
95. Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism.
Allensworth JL; Sauer SJ; Lyerly HK; Morse MA; Devi GR
Breast Cancer Res Treat; 2013 Jan; 137(2):359-71. PubMed ID: 23225169
[TBL] [Abstract][Full Text] [Related]
96. FAIM-L is an IAP-binding protein that inhibits XIAP ubiquitinylation and protects from Fas-induced apoptosis.
Moubarak RS; Planells-Ferrer L; Urresti J; Reix S; Segura MF; Carriba P; Marqués-Fernàndez F; Sole C; Llecha-Cano N; Lopez-Soriano J; Sanchis D; Yuste VJ; Comella JX
J Neurosci; 2013 Dec; 33(49):19262-75. PubMed ID: 24305822
[TBL] [Abstract][Full Text] [Related]
97. The inhibitor of apoptosis protein-binding domain of Smac is not essential for its proapoptotic activity.
Roberts DL; Merrison W; MacFarlane M; Cohen GM
J Cell Biol; 2001 Apr; 153(1):221-8. PubMed ID: 11285287
[TBL] [Abstract][Full Text] [Related]
98. A novel ubiquitin fusion system bypasses the mitochondria and generates biologically active Smac/DIABLO.
Hunter AM; Kottachchi D; Lewis J; Duckett CS; Korneluk RG; Liston P
J Biol Chem; 2003 Feb; 278(9):7494-9. PubMed ID: 12511567
[TBL] [Abstract][Full Text] [Related]
99. Small-molecule SMAC mimetics as new cancer therapeutics.
Bai L; Smith DC; Wang S
Pharmacol Ther; 2014 Oct; 144(1):82-95. PubMed ID: 24841289
[TBL] [Abstract][Full Text] [Related]
100. Enhanced cytoprotective effects of the inhibitor of apoptosis protein cellular IAP1 through stabilization with TRAF2.
Csomos RA; Brady GF; Duckett CS
J Biol Chem; 2009 Jul; 284(31):20531-9. PubMed ID: 19506082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
